Arcus Capital Partners LLC Acquires 326 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Arcus Capital Partners LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,373 shares of the healthcare conglomerate’s stock after buying an additional 326 shares during the period. Arcus Capital Partners LLC’s holdings in UnitedHealth Group were worth $679,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Richelieu Gestion SA acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $26,000. CGC Financial Services LLC boosted its holdings in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the period. True Wealth Design LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $31,000. LFA Lugano Financial Advisors SA boosted its holdings in shares of UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the period. Finally, Red Tortoise LLC boosted its holdings in shares of UnitedHealth Group by 45.1% in the first quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after buying an additional 23 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of UNH opened at $489.89 on Thursday. The firm has a market capitalization of $450.89 billion, a PE ratio of 29.94, a PEG ratio of 1.47 and a beta of 0.60. The company’s 50-day moving average is $498.64 and its 200-day moving average is $501.12. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the firm earned $6.26 earnings per share. The company’s revenue was up 8.6% on a year-over-year basis. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a dividend yield of 1.71%. UnitedHealth Group’s dividend payout ratio is 51.34%.

Analysts Set New Price Targets

UNH has been the subject of several research analyst reports. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, June 28th. Bank of America reissued a “buy” rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Wells Fargo & Company cut their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective on the stock in a research report on Wednesday, June 5th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.